Global Blood Therapeutics, Inc.
GBT · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $261 | $392 | $685 | $383 |
| Short-Term Investments | $256 | $162 | $0 | $3 |
| Receivables | $30 | $28 | $29 | $24 |
| Inventory | $66 | $62 | $58 | $52 |
| Other Curr. Assets | $27 | $33 | $30 | $27 |
| Total Curr. Assets | $640 | $676 | $802 | $489 |
| Property Plant & Equip (Net) | $79 | $81 | $83 | $84 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $147 | $109 | $50 | $31 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $4 | $4 | $4 |
| Total NC Assets | $230 | $194 | $137 | $119 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $870 | $870 | $939 | $608 |
| Liabilities | – | – | – | – |
| Payables | $8 | $5 | $15 | $9 |
| Short-Term Debt | $6 | $6 | $6 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $79 | $68 | $67 | $60 |
| Total Curr. Liab. | $93 | $79 | $88 | $74 |
| LT Debt | $652 | $653 | $654 | $224 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $3 | $1 | $1 |
| Total NC Liab. | $659 | $656 | $655 | $225 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $752 | $736 | $743 | $299 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,453 | -$1,371 | -$1,290 | -$1,202 |
| AOCI | -$4 | -$2 | $0 | $0 |
| Other Equity | $1,576 | $1,507 | $1,486 | $1,510 |
| Total Equity | $118 | $134 | $196 | $308 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $870 | $870 | $939 | $608 |
| Net Debt | $397 | $267 | -$25 | -$153 |